Neximmune Inc banner

Neximmune Inc
OTC:NEXI

Watchlist Manager
Neximmune Inc Logo
Neximmune Inc
OTC:NEXI
Watchlist
Price: 0.0002 USD Market Closed
Market Cap: $278

Profitability Summary

Neximmune Inc's profitability score is 21/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

21/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

21/100
Profitability
Score
21/100
Profitability
Score

Margins

Earnings Waterfall
Neximmune Inc

Margins Comparison
Neximmune Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
Neximmune Inc
F:737
86.1m EUR
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
409.4B USD
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
197.3B USD
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
179.1B USD
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.8B USD
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81B USD
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
69.8B AUD
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
39.7B EUR
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Neximmune Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Neximmune Inc
F:737
86.1m EUR
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
409.4B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
197.3B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
179.1B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.8B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
69.8B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
39.7B EUR
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Neximmune Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett